Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Hosted on MSN11mon
What to Do If Your Insulin Is Being Discontinued
Novo Nordisk is discontinuing one of its discounted ... Zilbermint highlights Lantus (insulin glargine) as a good option. Although Levermir and Lantus have different chemical structures, both ...
pharmaphorum6d
Patients resist Novo Nordisk plan to stop making Levemir
Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine) and biosimilars and Novo Nordisk's newer product Tresiba ...
pharmaphorum8d
California sues insulin producers and PBMs over pricing
Last year, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.
BBC1y
Drug giant Sanofi becomes latest to cap US insulin prices
The French firm announced a $35 (£28) per month price cap on Lantus for those with private insurance. Sanofi's changes follow in the footsteps of other drugmakers, Eli Lilly and Novo Nordisk.
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Medscape3d
Room-temperature Storage of Medications Labeled for Refrigeration
injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% ...
New York Post1mon
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...